Clinical Trials Browser

Phase 3 × Non-Muscle Invasive Bladder Neoplasms × 30 days × Clear all

NCT06211764 2026-06-05

SunRISe-5

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT06319820 2026-06-05

MoonRISe-1

Phase 3 Recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT06919965 2026-06-05

MoonRISe-3

Phase 3 Recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT07000084 2026-06-02

GAIN-BCG

Phase 3 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07424287 2026-06-02

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Phase 3 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT05943106 2026-05-26

PATAPSCO

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT02106572 2026-05-22

TIM

Phase 3 Terminated

Non-Muscle Invasive Bladder Neoplasms

NCT07551544 2026-05-19

ANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed High-Grade Non-Muscle Invasive Papillary Bladder Cancer

Phase 3 Withdrawn

Non-Muscle Invasive Bladder Neoplasms